These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1162 related items for PubMed ID: 25190166

  • 1. [Treatment outcome of childhood standard-risk and median-risk acute lymphoblastic leukemia with CCLG-2008 protocol].
    Liu X, Zou Y, Wang H, Chen X, Ruan M, Chen Y, Yang W, Guo Y, Liu T, Zhang L, Wang S, Zhang J, Liu F, Cai X, Qi B, Chang L, Zhu X.
    Zhonghua Er Ke Za Zhi; 2014 Jun; 52(6):449-54. PubMed ID: 25190166
    [Abstract] [Full Text] [Related]

  • 2. Prediction of outcomes by early treatment responses in childhood T-cell acute lymphoblastic leukemia: a retrospective study in China.
    Wei W, Chen X, Zou Y, Chang L, An W, Wan Y, Liu T, Yang W, Chen Y, Guo Y, Zhu X.
    BMC Pediatr; 2015 Jul 15; 15():80. PubMed ID: 26174476
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Evaluation of the efficacy of two successive protocols on pediatric acute lymphoblastic leukemia with E2A-PBX1 fusion gene].
    Mei YY, Gao C, Cui L, Zhao XX, Zhao W, Li WJ, Wang KL, Jiang J, Zhang RD, Xie J, Shi HW, Wang B, Zhang YH, Ma XL, Zhou X, Wu MY, Li ZG.
    Zhonghua Er Ke Za Zhi; 2013 Jun 15; 51(6):467-71. PubMed ID: 24120066
    [Abstract] [Full Text] [Related]

  • 7. [Clinical significance of dynamic monitoring the minimal residual disease in childhood B-lineage acute lymphoblastic leukemia by multiparameter flow cytometry].
    Guo DD, Zhao WL, Zhang YL, Pang L, Che L, He HL, Chai YH, Ji ZH, Ji XQ.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Dec 15; 20(6):1346-51. PubMed ID: 23257430
    [Abstract] [Full Text] [Related]

  • 8. [Comparison of the efficacy of two chemotherapy protocols for children with TEL-AML1[STBZ] fusion gene positive acute lymphoblastic leukemia].
    Wang KL, Mei YY, Cui L, Gao C, Liu FF, Zhao XX, Li WJ, Jiang J, Zhang RD, Xie J, Shi HW, Wang B, Zhang YH, Ma XL, Wu MY, Zhou X, Li ZG.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Apr 15; 22(2):285-90. PubMed ID: 24762993
    [Abstract] [Full Text] [Related]

  • 9. [Clinical significance of glucocorticoid induction test in Chinese childhood acute lymphoblastic leukemia].
    Fan JJ, Chai YH, Hu SY, He HL, Zhao WL, Wang Y, Li J, Lu J, Xiao PF, Sun YN, Wang W, Cao L.
    Zhonghua Er Ke Za Zhi; 2013 Jul 15; 51(7):523-6. PubMed ID: 24267134
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Residual bone marrow leukemic progenitor cell burden after induction chemotherapy in pediatric patients with acute lymphoblastic leukemia.
    Uckun FM, Stork L, Seibel N, Sarquis M, Bedros C, Sather H, Sensel M, Reaman GH, Gaynon PS.
    Clin Cancer Res; 2000 Aug 15; 6(8):3123-30. PubMed ID: 10955793
    [Abstract] [Full Text] [Related]

  • 12. [Prognostic value of both detection of lymphoblasts in the period of early treatment and minimal residual disease in childhood acute lymphoblastic leukemia].
    Tie LJ, Gu LJ, Song DL, Jiang LM, Xue HL, Tang JY, Dong L, Pan C, Chen J, Ye H, Wang YP, Chen J.
    Zhonghua Xue Ye Xue Za Zhi; 2005 Jan 15; 26(1):6-9. PubMed ID: 15946500
    [Abstract] [Full Text] [Related]

  • 13. Risk of relapse of childhood acute lymphoblastic leukemia is predicted by flow cytometric measurement of residual disease on day 15 bone marrow.
    Basso G, Veltroni M, Valsecchi MG, Dworzak MN, Ratei R, Silvestri D, Benetello A, Buldini B, Maglia O, Masera G, Conter V, Arico M, Biondi A, Gaipa G.
    J Clin Oncol; 2009 Nov 01; 27(31):5168-74. PubMed ID: 19805690
    [Abstract] [Full Text] [Related]

  • 14. Reduced intensity of early intensification does not increase the risk of relapse in children with standard risk acute lymphoblastic leukemia - a multi-centric clinical study of GD-2008-ALL protocol.
    Li XY, Li JQ, Luo XQ, Wu XD, Sun X, Xu HG, Li CG, Liu RY, Sun XF, Chen HQ, Lin YD, Li CK, Fang JP.
    BMC Cancer; 2021 Jan 13; 21(1):59. PubMed ID: 33435902
    [Abstract] [Full Text] [Related]

  • 15. Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia after first relapse.
    Coustan-Smith E, Gajjar A, Hijiya N, Razzouk BI, Ribeiro RC, Rivera GK, Rubnitz JE, Sandlund JT, Andreansky M, Hancock ML, Pui CH, Campana D.
    Leukemia; 2004 Mar 13; 18(3):499-504. PubMed ID: 14981525
    [Abstract] [Full Text] [Related]

  • 16. Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood.
    van Dongen JJ, Seriu T, Panzer-Grümayer ER, Biondi A, Pongers-Willemse MJ, Corral L, Stolz F, Schrappe M, Masera G, Kamps WA, Gadner H, van Wering ER, Ludwig WD, Basso G, de Bruijn MA, Cazzaniga G, Hettinger K, van der Does-van den Berg A, Hop WC, Riehm H, Bartram CR.
    Lancet; 1998 Nov 28; 352(9142):1731-8. PubMed ID: 9848348
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Evaluation on protocol SCMS-ALL-2005 for childhood B lineage acute lymphoblastic leukemia].
    Tang JY, Xue HL, Chen J, Pan C, Li BS, Gu LJ, Dong L, Hu WT, Shen SH, Zhou M, Ye QD, Jiang H, Luo CY.
    Zhonghua Yi Xue Za Zhi; 2012 Feb 28; 92(8):546-50. PubMed ID: 22490159
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 59.